2-3

Cipla known for its innovative pharmaceutical products backed by latest in technology and creative marketing practices, is enjoying a commanding position among the top pharma companies in the country. Several specialised therapeutic divisions and promising new products have been launched and many more are in the pipeline.

Established in the year 1978 as an exclusive facility for Small Volume Parenterals (SVPs), Gland Pharma has developed into a progressive and quality conscious organization serving the pharmaceutical needs of diverse markets across the globe.
The Company has world-class & world-scale facilities for injectables set up in collaboration with Vetter Group, Germany. The collaboration with Vetter provides Gland Pharma a technological edge in injectables and specifically in Pre Filled Syringes.

Alembic Limited, with an established presence in the Indian pharma  industry has a proud, historical track record going back one hundred years. With a turnover in excess of Rs1000 crores today, Alembic Limited is one of India’s leading integrated pharmaceutical companies. We continue to enjoy leadership positions in antibiotics, anti-infective, anti-cough and also have significant worldwide presence in specialty therapeutic areas such as cardiology, neurology, diabetology, etc. We have also plans for expansion in Ophthalmic etc.

Bristol-Myers Squibb Biocon R&D Center (BBRC) is a collaboration between Bristol-Myers Squibb and Syngene International, a subsidiary of the Indian biotechnology major, Biocon. This initiative is intended to help advance Bristol-Myers Squibb's work in discovery and early drug development. The center is expanding its capabilities to clinical biomarkers, toxicology and first-in-human studies. The aim is to develop internationally benchmarked research infrastructure and enlist outstanding scientific talent to help patients prevail against serious diseases. So come, research India with us.

Post : Reseach Investigator I

Ipca is a fully integrated, rapidly growing Indian pharmaceutical company with a strong thrust on exports. Ipca's APIs and Formulations produced at worldclass manufacturing facilities are approved by leading drug regulatory authorities including the US-Food and Drug Administration (FDA), UK-Medicines and Healthcare products Regulatory Agency (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-Therapeutic Goods Administration (TGA). With operations in over 100 countries, exports account for over 52%  of the company's income.

Hetero Drugs established in the year 1993, with the motto to be the best in the API manufacturing, Hetero today embodies the vision of a top notch player in developing and commercialising products catering to a variety of therapeutic categories, integrating into a leading finished dosage manufacturer.

Sri Krishna Pharmaceuticals Limited (SKPL), established in 1974, pioneering the manufacture of ACETAMINOPHEN (PARACETAMOL) for the domestic market, is today a renowned and leading supplier of 150+ niche drugs for marquee global customers.Trusted by customers worldwide, we are today, the only organisation in the world to have a USFDA certified facility for the manufacturing of Folic Acid - a product par excellence

Post : Formulation Analytical Research And Development

Theon Pharmaceuticals Ltd is a pioneering WHO GMP certified pharma company with ultra modern and sophisticated plant situated at NALAGARH in Himachal Pradesh, having strategic tie ups with MNCs. The company has set up a state of the art facility for manufacturing of pharmaceutical formulations viz.Tablets, capsules & dry syrups (β-lactum, cephalosporin’s & general block) with installed capacity of about 1000 million units per annuam.
The company is presently engaged in contract segments of cardiology, diabetology, neurology, anti- depressants, anti allergic, anti-asthmatic, and anti-infective with manufacturing of new & specialized DCGI Products.